Randomised controlled trial of perinatal vitamin D supplementation to prevent early-onset acute respiratory infections among Australian First Nations children: the 'D-Kids' study protocol

被引:4
|
作者
Binks, Michael J. [1 ]
Bleakley, Amy S. [1 ]
Pizzutto, Susan J. [1 ]
Lamberth, Michelle [1 ,2 ]
Powell, Verity [1 ,2 ]
Nelson, Jane [1 ]
Kirby, Adrienne [3 ]
Morris, Peter S. [1 ,4 ]
Simon, David [2 ]
Mulholland, E. Kim [5 ,6 ]
Rathnayake, Geetha [7 ]
Leach, Amanda J. [1 ]
D'Antoine, Heather [1 ]
Licciardi, Paul, V [5 ,8 ]
Snelling, Tom [9 ,10 ]
Chang, Anne B. [1 ,11 ]
机构
[1] Charles Darwin Univ, Menzies Sch Hlth Res, Child Hlth Div, Casuarina, NT, Australia
[2] Royal Darwin Hosp, Dept Obstet & Gynaecol, Tiwi, NT, Australia
[3] Univ Sydney CAR, Natl Hlth & Med Res Council, Clin Trials Ctr, Glebe, NSW, Australia
[4] Royal Darwin Hosp, Dept Paediat, Tiwi, NT, Australia
[5] Murdoch Childrens Res Inst, New Vaccines Res Grp, Parkville, Vic, Australia
[6] London Sch Hyg & Trop Med, Epidemiol & Publ Hlth, London, England
[7] Virtus Diagnost, Sydney, NSW, Australia
[8] Univ Melbourne VCCC, Dept Paediat, Parkville, Vic, Australia
[9] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia
[10] Telethon Kids Inst, Wesfarmers Ctr Vaccines & Infect Dis, Nedlands, WA, Australia
[11] Queensland Univ Technol, Ctr Childrens Hlth Res, Brisbane, Qld, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Respiratory Infection; Bacterial Infection; Viral infection; Pneumonia; Infection Control; Innate Immunity; DRIED BLOOD SPOTS; NORTHERN-TERRITORY; NASOPHARYNGEAL CARRIAGE; INDIGENOUS CHILDREN; OTITIS-MEDIA; DOUBLE-BLIND; D DEFICIENCY; PREGNANCY; HEALTH; INFANTS;
D O I
10.1136/bmjresp-2023-001646
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
IntroductionGlobally, acute respiratory infections (ARIs) are a leading cause of childhood morbidity and mortality. While ARI-related mortality is low in Australia, First Nations infants are hospitalised with ARIs up to nine times more often than their non-First Nations counterparts. The gap is widest in the Northern Territory (NT) where rates of both acute and chronic respiratory infection are among the highest reported in the world. Vitamin D deficiency is common among NT First Nations neonates and associated with an increased risk of ARI hospitalisation. We hypothesise that perinatal vitamin D supplementation will reduce the risk of ARI in the first year of life. Methods and analysis'D-Kids' is a parallel (1:1), double-blind (allocation concealed), randomised placebo-controlled trial conducted among NT First Nations mother-infant pairs. Pregnant women and their babies (n=314) receive either vitamin D or placebo. Women receive 14 000 IU/week or placebo from 28 to 34 weeks gestation until birth and babies receive 4200 IU/week or placebo from birth until age 4 months. The primary outcome is the incidence of ARI episodes receiving medical attention in the first year of life. Secondary outcomes include circulating vitamin D level and nasal pathogen prevalence. Tertiary outcomes include infant immune cell phenotypes and challenge responses. Blood, nasal swabs, breast milk and saliva are collected longitudinally across four study visits: enrolment, birth, infant age 4 and 12 months. The sample size provides 90% power to detect a 27.5% relative reduction in new ARI episodes between groups. Ethics and disseminationThis trial is approved by the NT Human Research Ethics Committee (2018-3160). Study outcomes will be disseminated to participant families, communities, local policy-makers, the broader research and clinical community via written and oral reports, education workshops, peer-reviewed journals, national and international conferences.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Weekly Vitamin D Supplementation to Prevent Acute Respiratory Infections in Young Children at Different Latitudes: A Randomized Controlled Trial
    Reyes, Maria Loreto
    Vizcaya, Cecilia
    Le Roy, Catalina
    Loureiro, Carolina
    Brinkmann, Karin
    Campos, Laura
    Arancibia, Monica
    Iturriaga, Carolina
    Perez-Mateluna, Guillermo
    Rojas-McKenzie, Maite
    Dominguez, Gonzalo
    Camargo Jr, Carlos A.
    Borzutzky, Arturo
    JOURNAL OF PEDIATRICS, 2024, 275
  • [2] Azithromycin to prevent acute lower respiratory infections among Australian and New Zealand First Nations and Timorese children (PETAL trial): study protocol for a multicentre, international, double-blind, randomised controlled trial
    Mccallum, Gabrielle B.
    Byrnes, Catherine A.
    Morris, Peter S.
    Grimwood, Keith
    Marsh, Robyn L.
    Chatfield, Mark D.
    Bowden, Emily R.
    Schutz, Kobi L.
    Sarmento, Nevio
    Fancourt, Nicholas
    Francis, Joshua
    Zhao, Yuejen
    Vieira, Adriano
    Hare, Kim M.
    Bonney, Dennis
    Trenholme, Adrian
    Lawrence, Shirley
    Marwick, Felicity
    Karvonen, Bronwyn
    Maclennan, Carolyn
    Connors, Christine
    Smith-Vaughan, Heidi
    Lay, Milena Santos
    da Silva, Endang Soares
    Chang, Anne B.
    BMJ OPEN, 2025, 15 (02):
  • [3] Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children
    Antonio Buendia, Jefferson
    Guerrero Patino, Diana
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2023, 21 (01)
  • [4] Does vitamin D supplementation prevent acute lower respiratory tract infections in children?
    Ali, Salma Rashid
    McDevitt, Helen
    ARCHIVES OF DISEASE IN CHILDHOOD, 2015, 100 (09) : 892 - +
  • [5] Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children
    Jefferson Antonio Buendía
    Diana Guerrero Patiño
    Cost Effectiveness and Resource Allocation, 21
  • [6] Effects of Vitamin D Supplementation and Baseline Vitamin D Status on Acute Respiratory Infections and Cathelicidin: A Randomized Controlled Trial
    Laaksi, Akseli
    Kyrolainen, Heikki
    Pihlajamaki, Harri
    Vaara, Jani P.
    Luukkaala, Tiina
    Laaksi, Ilkka
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (09):
  • [7] VITAMIN D TO PREVENT COVID-19 OR OTHER ACUTE RESPIRATORY INFECTIONS: PHASE 3 RANDOMISED CONTROLLED TRIAL (CORONAVIT)
    Jolliffe, D. A.
    Holt, H.
    Talaei, M.
    Sheikh, A.
    Griffiths, C. J.
    Shaheen, S. O.
    Relton, C.
    Martineau, A. R.
    THORAX, 2022, 77 : A29 - A29
  • [8] Vitamin D to prevent COVID-19 or other acute respiratory infections: phase 3 randomised controlled trial (CORONAVIT)
    Jolliffe, D. A.
    Holt, H.
    Talaei, M.
    Sheikh, A.
    Griffiths, C. J.
    Shaheen, S. O.
    Relton, C.
    Martineau, A. R.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [9] Vitamin D supplementation for the prevention of childhood acute respiratory infections: a systematic review of randomised controlled trials
    Xiao, Limin
    Xing, Chao
    Yang, Zhongrong
    Xu, Shaojun
    Wang, Min
    Du, Huarong
    Liu, Kai
    Huang, Zhaohui
    BRITISH JOURNAL OF NUTRITION, 2015, 114 (07) : 1026 - 1034
  • [10] MOnitored supplementation of VItamin D in preterm infants (MOSVID trial): study protocol for a randomised controlled trial
    Alicja Kołodziejczyk
    Maria K. Borszewska-Kornacka
    Joanna Seliga-Siwecka
    Trials, 18